Skip to main content

Table 1 Characteristics of studies included in the meta-analysis

From: Efficacy and safety of short-term chemotherapy for patients with spinal tuberculosis undergoing surgery in Chinese population: a meta-analysis

References

Year of publication

Country

Design

Mean follow-up (month)

Basic data

Treatment

QAS

Group A

Group B

Group A

Group B

 

Sample size

Age in years (mean±SD)

Male (%)

Sample size

Age in years (mean±SD)

Male (%)

Hong Liu et al. [20]

2017

China

RCT

36

98

40.7±4.2

51(52%)

98

40.1±4.7

50(51%)

2SHRZ/2–4HRZ

2SHRZ/7–16HRZ

3

Bo Wang et al. [21]

2015

China

RCT

NA

40

42.11±2.09

28(70%)

40

42.34±2.21

27(68%)

2SHRZ/2~4HRZ

2SHRZ/10–16HRZ

4

Yongli He et al. [22]

2015

China

RS

71

100

41.7±5.4

58(%)

91

41.3±5.8

50(55%)

2SHRZ/2–4HRZ

2SHRZ/7–16HRZ

7

Yirong Zheng et al. [23]

2014

China

RS

78.6

38

NA

NA

38

NA

NA

2SHRZ/2–4HRZ

2SHRZ/7–16HRZ

6

Upadhyay et al. [19]

1996

China

RCT

175.2

25

32.6±18.3

9(36%)

89

NA

46(52%)

3SHR/3HR

3SHR/6HR or 3H+S+ PASNa/15S+ PASNa

4

Zili Wang et al. [14]

2013

China

PS

69.1

96

37.96 ± 16.3

54(56%)

89

41.53 ± 15.76

50(56%)

2SHRZ/2–4HRZ

2SHRZ/7HRZ

8

  1. NA Not available, RCT Randomized controlled trial, RS Retrospective study, PS Prospective study, R Rifampicin, H Isoniazid, Z Pyrazinamide, S Streptomycin, PASNa Sodium para-aminosalicylic acid, QAS Quality assessment score: the Newcastle-Ottawa Scale (NOQAS) was used for assessing the quality of retrospective study or prospective study, the Revised Jadad’s scale was used for RCT